Medicare Enrolled
Dr. Ammar Qoubaitary, M.D.
Endocrinology · San Ramon, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qoubaitary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qoubaitary?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qoubaitary
Dr. Ammar Qoubaitary is an endocrinology specialist in San Ramon, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Qoubaitary performed 22,361 Medicare services across 1,100 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qoubaitary received a total of $482,560 from 75 pharmaceutical and/or device companies across 1758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qoubaitary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 4% volume in CA
$482,560 industry payments
Medicare Practice Summary
Medicare Utilization ↗22,361
Medicare services
Top 4% in CA for endocrinology
1,100
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,177 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Romosozumab injection (Evenity) for osteoporosis | 15,330 | $8 | $22 |
| Denosumab injection (Prolia/Xgeva) | 5,580 | $17 | $52 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
666 | $108 | $305 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
194 | $13 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
190 | $71 | $210 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
105 | $142 | $461 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
102 | $112 | $400 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
56 | $130 | $429 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
34 | $56 | $664 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $148 | $406 |
| New patient office visit, complex (60-74 min) | 29 | $176 | $569 |
| Ultrasound-guided fine needle aspiration biopsy, each additional growth This procedure involves using ultrasound guidance to perform a fine needle aspiration biopsy on an additional growth during the same session. |
21 | $56 | $429 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
21 | $32 | $121 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$482,560
Total received (2018-2024)
Avg $68,937/year across 7 years
Top 2% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
1,758
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$443,280 (91.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$21,379 (4.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,900 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$45,835
2023
$48,150
2022
$78,864
2021
$88,212
2020
$43,283
2019
$109,858
2018
$68,356
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$29,069
Lilly USA, LLC
$7,659
Boehringer Ingelheim Pharmaceuticals, Inc.
$5,420
Amgen Inc.
$1,212
IBSA Pharma Inc.
$686
BETA BIONICS, INC.
$228
Radius Health, Inc.
$172
Currax Pharmaceuticals LLC
$159
AstraZeneca Pharmaceuticals LP
$153
Madrigal Pharmaceuticals
$143
Bayer Healthcare Pharmaceuticals Inc.
$136
Alexion Pharmaceuticals, Inc.
$96
Mannkind Corporation
$66
Ascensia Diabetes Care Us Inc.
$63
PFIZER INC.
$62
Antares Pharma, Inc.
$58
ABBVIE INC.
$55
Xeris Pharmaceuticals, Inc.
$54
SANOFI-AVENTIS U.S. LLC
$37
Dexcom, Inc.
$33
GlaxoSmithKline, LLC.
$33
Otsuka America Pharmaceutical, Inc.
$30
Dynavax Technologies Corporation
$25
Averitas Pharma Inc.
$25
Insulet Corporation
$25
Kyowa Kirin, Inc.
$24
Almatica Pharma LLC
$24
Astellas Pharma US Inc
$20
Abbott Laboratories
$20
Phadia US Inc.
$19
Bausch Health US, LLC
$16
Lundbeck LLC
$13
Top 3 companies account for 92.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$259,128
Janssen Pharmaceuticals, Inc
$72,125
Boehringer Ingelheim Pharmaceuticals, Inc.
$33,518
AstraZeneca Pharmaceuticals LP
$30,405
Lilly USA, LLC
$25,071
Amarin Pharma Inc.
$22,139
IBSA Pharma Inc.
$8,821
Amgen Inc.
$8,597
SANOFI-AVENTIS U.S. LLC
$8,449
Corcept Therapeutics
$2,389
Radius Health, Inc.
$1,372
Cambridge Interventional LLC
$1,312
Dexcom, Inc.
$858
Horizon Therapeutics plc
$627
Bayer HealthCare Pharmaceuticals Inc.
$552
Abbott Laboratories
$436
Bayer Healthcare Pharmaceuticals Inc.
$431
MannKind Corporation
$424
Alexion Pharmaceuticals, Inc.
$422
Merck Sharp & Dohme Corporation
$415
ABBVIE INC.
$338
PFIZER INC.
$316
Mannkind Corporation
$316
Biohaven Pharmaceuticals, Inc.
$281
AbbVie Inc.
$257
BETA BIONICS, INC.
$228
Medtronic, Inc.
$227
Antares Pharma, Inc.
$208
AbbVie, Inc.
$206
Currax Pharmaceuticals LLC
$188
Biohaven Pharmaceutical Holding Company Ltd.
$184
Xeris Pharmaceuticals, Inc.
$176
Madrigal Pharmaceuticals
$143
Allergan, Inc.
$135
Shire North American Group Inc
$111
Bausch Health US, LLC
$105
Kowa Pharmaceuticals America, Inc.
$102
Tandem Diabetes Care, Inc.
$101
Esperion Therapeutics, Inc.
$87
Embecta Corp.
$86
GlaxoSmithKline, LLC.
$84
DEXCOM, INC.
$83
Insulet Corporation
$81
Merck Sharp & Dohme LLC
$79
Regeneron Healthcare Solutions, Inc.
$76
Supernus Pharmaceuticals, Inc.
$69
Ascensia Diabetes Care Us Inc.
$63
Ascendis Pharma Inc
$60
Exact Sciences Corporation
$58
Averitas Pharma Inc.
$51
LifeScan, Inc.
$37
Takeda Pharmaceuticals U.S.A., Inc.
$36
GRT US Holding, Inc.
$31
Amryt Pharma Holdings Ltd
$30
Otsuka America Pharmaceutical, Inc.
$30
Companion Medical, Inc.
$29
Ascendis Pharma, Inc.
$25
Dynavax Technologies Corporation
$25
Kyowa Kirin, Inc.
$24
Almatica Pharma LLC
$24
Senseonics, Incorporated
$24
Acella Pharmaceuticals, LLC
$23
Endo Pharmaceuticals Inc.
$23
VBI Vaccine (Delaware) Inc.
$22
IMPEL PHARMACEUTICALS INC.
$22
Astellas Pharma US Inc
$20
Aegerion Pharmaceuticals, Inc.
$20
Horizon Pharma plc
$20
CeQur Corporation
$19
Mylan Pharmaceuticals Inc.
$19
Phadia US Inc.
$19
Bigfoot Biomedical Inc
$16
Lundbeck LLC
$13
Clarus Therapeutics Inc.
$12
Janssen Scientific Affairs, LLC
$6
Top 3 companies account for 75.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · APLENZIN · Aimovig · BAQSIMI · BD Nano 2nd Gen Pen Needle · BOTOX · BREZTRI · BYDUREON · COLOGUARD · CONTRAVE · CRF · CeQur Simplicity · Cologuard Collection Kit · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIABETES - DISEASE · DIFICID · DISEASE STATE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · EVKEEZA · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · Heplisav-B · INVOKANA · ImmunoCAP · InPen · JANUVIA · JARDIANCE · JATENZO · KRYSTEXXA · Kerendia · Korlym · LICART · Levemir · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYALEPT · MYCAPSSA · NASCOBAL · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid 60 · NURTEC ODT · ONZETRA XSAIL · OT Verio Reflect "One Touch Meter and Strips" · Omnipod · OneTouch · Otezla · Otrexup · Ozempic · PNEUMOVAX 23 · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREMARIN · PREVNAR 13 · PREVNAR 20 · PreHevbrio · Prolia · QUTENZA · Qutenza · RECORLEV · RETEVMO · REXULTI · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SPIRIVA RESPIMAT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · Strensiq · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRINTELLIX · TRULICITY · Tirosint · Tresiba · Trudhesa · Tymlos · UBRELVY · UNITY DIABETES MANAGEMENT SYSTEM · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xulane · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in CA.
Geographic Context
Endocrinologists within 10 mi
96
Per 100K population
8.3
County median income
$125,727
Nearest hospital
SAN RAMON REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qoubaitary is a mixed practice specialist, with above-average Medicare volume (top 4% in CA), with speaking/promotional industry engagement in the top 2% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qoubaitary experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Qoubaitary performed 15,330 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qoubaitary receive payments from pharmaceutical companies?
Yes. Dr. Qoubaitary received a total of $482,560 from 75 companies across 1,758 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qoubaitary's costs compare to other endocrinologists in San Ramon?
Dr. Qoubaitary's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qoubaitary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in San Ramon
Browse endocrinologists in San Ramon ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in CA
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in CA
Which CA endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology